Transaction · 0001464583-26-000008

Megna Michael R

Megna Michael R, CAO, reported a transaction classified as grant at Kiniksa Pharmaceuticals International, plc involving 279.000000 shares for an estimated $9346.50. Reported holdings after the transaction were 27697.000000 shares. The stored filing text includes a detected 10b5-1 reference.

grantSEC transaction code ACAO
KNSAKiniksa Pharmaceuticals International, plc
Trade date
Jul 15, 2026
Filing date
Sep 03, 2026
View on SEC Insider profile
Estimated value$9.34kShares × reported price
Shares traded279$33.50 per share
Holdings after27.6kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 50 calendar days after the transaction date.

KNSA price since this filing

Daily closing prices, with the filing date and available return windows
KNSA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -39.8%1w ago -19.5%1d ago -23.0%
Returns since7d -5.0%30d -5.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001464583-26-000008
Class A Ordinary Share
Transaction date
Jul 15, 2026
Filed Sep 03, 2026, 08:40 PM · 50d delay
Shares
279 sh
$33.50 per share
Estimated value
$9.34k
Computed from shares × price
Holdings after
27,697 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Delayed Filing Direct Ownership 10b5-1 Detected
Filing-only score

-32 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • grant_or_award-22 points

    transaction_code = A

    Grant or award transactions are scheduled compensation, not discretionary.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
  • delayed_filing-6 points

    reporting_delay_days = 50

    Filing delay exceeds the configured threshold.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF ACCOUNTING OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2026 to July 15, 2026. T…

  2. F2

    Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

  3. F3

    This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025.

  4. F4

    The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026.

  5. F5

    The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting comme…

  6. F6

    The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025.

  7. F7

    The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024.

  8. F8

    The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.

  9. F9

    The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.

Original filing · 0001464583-26-000008
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

KNSA